Concepedia

Publication | Open Access

Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-Adjuvanted Prepandemic Candidate Influenza Vaccines in Children Aged 3 to 9 Years

DOIFull Paper Access

75

Citations

19

References

2010

Year

Javier Díez‐Domingo, María Garcés‐Sánchez, José‐María Baldó, María Victoria Planelles, Isabel Ubeda, Angels Jubert, Josep Marés, Philippe Moris, Pilar Garcı́a-Corbeira, Mamadou Dramé,
The Pediatric Infectious Disease Journal

Abstract

The results showed that 2 doses of AS03-adjuvanted H5N1 influenza vaccine at antigen-sparing doses of 1.9 microg or 3.75 microg HA elicited broad and persistent immune responses with acceptable reactogenicity, and without safety concerns, in children aged 3 to 9 years.

References

YearCitations

Page 1